Gainers

• INVO Fertility (NASDAQ:IVF) shares increased by 33.0% to $2.5 during Friday's after-market session. The market value of their outstanding shares is at $25.7 million.
• Lisata Therapeutics (NASDAQ:LSTA) stock moved upwards by 27.38% to $4.14. The market value of their outstanding shares is at $30.0 million.
• Alpha Cognition (NASDAQ:ACOG) shares moved upwards by 13.73% to $7.04. The market value of their outstanding shares is at $129.3 million.
• Polaryx Therapeutics (NASDAQ:PLYX) stock rose 8.85% to $3.56. The company's market cap stands at $144.3 million.
• P3 Health Partners (NASDAQ:PIII) shares increased by 6.73% to $13.0. The market value of their outstanding shares is at $54.7 million.
• XORTX Therapeutics (NASDAQ:XRTX) shares increased by 6.69% to $2.39. The company's market cap stands at $3.9 million.

Losers

• Aditxt (NASDAQ:ADTX) shares decreased by 37.7% to $0.07 during Friday's after-market session.
• Oculis Holding (NASDAQ:OCS) stock decreased by 22.55% to $17.8. The company's market cap stands at $1.7 billion.
• PRF Technologies (NASDAQ:PRFX) stock declined by 19.0% to $2.43. The company's market cap stands at $1.1 million.
• CollPlant Biotechnologies (NASDAQ:CLGN) stock decreased by 7.82% to $0.37. The market value of their outstanding shares is at $5.1 million. The company's, Q1 earnings came out today.
• QTREX Quantum (NASDAQ:QTEX) shares decreased by 6.85% to $2.86. The market value of their outstanding shares is at $130.7 million.
• Alpha Compute (NASDAQ:ALP) shares declined by 6.76% to $0.35. The company's market cap stands at $10.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.